25.02.2015
- With activist investors continuing to make headlines in the chemical industry, especially in the US, the struggles of Dow, DuPont and Botox producer Allergan are cases in point -...
04.09.2012
- Valeant Pharmaceuticals International agreed on Monday to buy Medicis Pharmaceutical for $2.6 billion in cash, in a deal that will add Botox competitor Dysport and other skin care...
